Skip to main content
SP5007,785.76-0.17%DOW53,732.41-0.20%NASDAQ26,729.16-0.28%BTC$62,945.00-0.85%ETH$1,880.32-0.35%GOLD$4,432.00+0.26%OIL$82.40+1.42%
Smart Investors Daily
Sign InSign Up Free
AP

NASDAQ · APOP

Cellect Biotechnology Ltd.

Healthcare · Biotechnology

$13.17

Up+$0.05 (+0.38%)

Updated Aug 16, 2026, 4:05 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
129.02M
P/E ratio
-0.36
Dividend yield
0.00%
52-week range
— – —
Volume
17.43K
Avg. volume
1.95M

Price performance

APOP price history

1M range · 0 trading sessions · Daily adjusted prices

APOP does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest APOP news

The latest Smart Investors Daily articles mentioning APOP.

Stock researchCompany · Overview

APOP research

Overview

Company profile and research snapshot.

Company profile

A detailed company description is not available yet.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
APOP recent ratings
DateFirmRatingTarget
Apr 4, 2017Rodman & RenshawBuy—
Nov 10, 2016Rodman & RenshawBuy—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Oct 15, 2021

Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals

Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the previously announced strategic merger with privately-held Quoin Pharmaceuticals, Inc., a specialty pharmaceutical company focused on rare and orphan diseases (the “Merger”) and the sale of the Company’s subsidiary, Cellect Biotherapeutics Ltd., to EnCellX, Inc., a privately held company based in San Diego, CA (the “Share Transfer”).

Benzinga · Oct 12, 2021

5 Short Squeeze Candidates To Watch: Bit Digital, Camber Energy Rejoin The List

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp. (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted strong interest and saw shares spike. A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if they have to buy back the shares they initially borrowed at a higher price. Fintel Data: Data from Fintel, which requires a subscription, provides a look at some of the top shorted stocks and data that shows how likely a short squeeze is to happen. Here is a look at Fintel’s top five short squeeze candidates for the week of Oct. 11. ReShape Lifesciences: Small-cap ReShape Lifesciences (NASDAQ: RSLS) tops the list from Fintel with a score of 96.61. The borrow fee rate on ...

GlobeNewswire Inc. · Sep 27, 2021

Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals

Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held Quoin Pharmaceuticals, a specialty pharmaceutical company focused on rare and orphan diseases, and all other proposals presented at the Special General Meeting of shareholders held on September 26, 2021, including the sale of the Company’s subsidiary, Cellect Biotherapeutics Ltd, to EnCellX Inc. , a privately held company based in San Diego, CA.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By